Stories about Forschung

Subscribe to Forschung

27.05.2020 – 11:00

Jennewein Biotechnologie GmbH
Jennewein publishes new results on the norovirus-inhibiting effect of complex oligosaccharides

Rheinbreitbach (ots) - Jennewein Biotechnologie GmbH today announces the publication of the latest results from its norovirus research program in the Journal of Biotechnology. Breast-fed infants are less likely than bottle-fed infants to contract norovirus infections, and earlier work has indicated a link between this protective effect and human milk oligosaccharides ...

more
19.05.2020 – 09:20

Bosch Healthcare Solutions GmbH

BioGX, Bosch Healthcare Solutions partner to expand molecular diagnostic tests offering for the Vivalytic platform / New biocontent cooperation with renowned US firm

more
15.05.2020 – 13:27

nova-Institut GmbH

PRESS RELEASE (EN/DE):Crises need clever minds - The winner of the innovation award "Bio-based Material of the Year 2020" is a wood fibre-based ready meal tray certified for home composting from Huhtamaki Lurgan (UK/Finland)!

Subscribe to nova's mailing lists

more
06.05.2020 – 16:05

Technische Universität München
Technical University of Munich (TUM) and Framatome develop new fuel based on a low enriched uranium-molybdenum alloy

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36033/ High resolution images: https://mediatum.ub.tum.de/1545311 NEWS RELEASE Pioneering work: ...

more
05.05.2020 – 11:13

nova-Institut GmbH

PRESS RELEASE (EN/DE): The world's largest meeting on industrial hemp and cannabis will take place online this year - 500 participants from 50 countries and all industrial sectors are expected

Subscribe to nova's mailing lists

more
04.05.2020 – 14:19

Germany Trade & Invest
New Corona Antibody Test Made in Germany "99.8% Accurate"

Berlin (ots) - Researchers in Penzberg, Bavaria have developed the test for Swiss pharmaceutical company Roche that is being hailed as a "milestone" in the fight against the coronavirus. Roche launched the new serological (antibody-based) test at the company's Penzberg laboratory on Monday, May 4 at a press conference attended by German Health Minister Jens Spahn and Bavarian state premier Markus Söder. On May 3, the ...

more
30.04.2020 – 13:54

China Matters
China Matters Releases A Documentary Film on China's FAST Telescope

more
20.04.2020 – 15:49

nova-Institut GmbH

PRESS RELEASE (EN/DE): 13th International Conference on Bio-based Materials” will be held ONLINE this year on 12–14 May 2020 – final programme available online

Subscribe to nova's mailing lists

more
30.03.2020 – 11:57

nova-Institut GmbH

PRESSEMITTEILUNG: Die Gewinner des Innovationspreises "Best CO2 Utilisation 2020" sind Air Vodka aus CO2, ein biologischer Methanisierungsprozess als Energiespeicherlösung im Netzmaßstab und eine direkte Luftabscheidungslösung für CO2.

Subscribe to nova's mailing lists

more
26.03.2020 – 18:22

Elastrin Therapeutics
Elastrin Therapeutics develops new approach against "Inflammatory Storm" that kills most Corona patients

Greenville South Carolina (ots) - A previously untested approach to preventing the most severe outcomes of lung diseases, including COVID-19, has been developed by Elastrin Therapeutics based on targeting damaged elastic fiber that leads to impaired lung function. The company has developed the world's first ...

more
26.03.2020 – 14:34

Bosch Healthcare Solutions GmbH

2
Bosch developing COVID-19-(SARS-CoV-2) rapid testing kit for the Vivalytic platform / Test delivers reliable results at the point of care in less than 2.5 hours

more
26.03.2020 – 14:08

Germany Trade & Invest
Germany Devotes EUR150 Million to Connect Research Hospitals into Anti-Corona Network

Berlin (ots) - The country's many centers of research excellence will now be centrally linked to speed efforts to combat the pandemic Germany's Education and Research Minister Anja Karliczek announced her ministry was investing EUR150 million in the project at a press conference with the chairman and the lead virologist of Berlin's Charité hospital, which will ...

more
25.03.2020 – 09:00

Debiopharm International SA
Debiopharm expands its radiopharmaceutical footprint with an exclusive in-licensing agreement of 3B Pharmaceutical's targeted CAIX radiotherapy

Lausanne (ots) - Debiopharm, a Swiss-based biopharmaceutical company announced today having entered into a worldwide, exclusive license & research agreement with 3B Pharmaceuticals (3BP), a German biotechnology firm, to further the development of their radioligand program, now called Debio 0228, which targets the ...

more
20.03.2020 – 13:27

Germany Trade & Invest
German companies at the heart of coronavirus vaccine efforts

Berlin (ots) - There is cautious optimism that biotechnology and pharmaceutic know-how from Germany can help produce a COVID-19 vaccine in the near future German companies CureVac and BioNTech were both in the headlines this week as companies working overtime to develop a vaccine to prevent the spread of coronavirus. That's no accident, say health experts. "Like all modern medicines, vaccines are high-tech products," says ...

more
19.03.2020 – 16:57

Zhejiang Hisun Pharmaceutical Co. Ltd.

2
Favipiravir works! Preliminary Clinical Studies Suggest Positive Effects on COVID-19 Patients

more
18.03.2020 – 12:16

nova-Institut GmbH

PRESS RELEASE (EN/DE): Aviation fuels, CO2-based fuels and chemicals, PtX and CCU need conferences and meeting places for exchange - especially in times of the corona virus

Subscribe to nova's mailing lists

more
10.03.2020 – 12:00

Sysmex Inostics GmbH
Sysmex Inostics' updated SafeSEQ Breast Cancer Panel advances novel clinical uses of ctDNA through quantitative testing

Baltimore, Maryland (ots) - Building on the ultra-high sensitivity SafeSEQ Breast Cancer Panel circulating tumor DNA (ctDNA) test launched at the American Association of Cancer Research 2019 annual meeting, Sysmex Inostics has updated the test to provide additional key information for investigation of the validity ...

more
05.03.2020 – 09:01

Debiopharm International SA
Debiopharm advances into the highly anticipated clinical phase for their potent WEE1 inhibitor

Lausanne (ots) - Debio 0123 starts first-in-human, dose escalation phase I clinical trial assessing the safety and efficacy of the compound in combination with carboplatin to treat refractory solid tumors Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced today the advancement of their first-in-human, phase 1 study with the cancer treatment ...

more
04.03.2020 – 11:07

Technische Universität München
QS Rankings: TUM among top 50 universities in 11 subjects

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22798 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35935/ NEWS RELEASE TUM among top 50 universities in 11 subjects New issue of “QS World University Rankings by Subject” The Technical University of Munich (TUM) ranks among the world's best 50 universities ...

more
28.02.2020 – 08:06

nova-Institut GmbH

PRESS RELEASE (EN/DE):Commercialisation updates on bio-based building blocks

Subscribe to nova's mailing lists

more
20.02.2020 – 13:32

nova-Institut GmbH

PRESS RELEASE (EN/DE): Despite storm and virus warnings, 210 participants joined "1st International Conference on Cellulose Fibres" in Cologne, Germany

Subscribe to nova's mailing lists

more
11.02.2020 – 12:49

Energy2market GmbH

Energy2market and Deutsche Post to Optimise Power Procurement and Energy Use at Logistics Sites / Conclusion of the government-subsidised research project TRADE EV

more
06.02.2020 – 20:30

RWTH Aachen Campus GmbH

The construction site of the future: digitized and networked - terrain handover for the reference construction site on Campus West

more
29.01.2020 – 10:27

Grünenthal Group
Grünenthal expands its network through Innovation Hub in Boston

Aachen, Germany and Boston, USA (ots) - Grünenthal announced today that it has officially inaugurated its Innovation Hub in Boston, Massachusetts to strengthen and expand its network with leading scientists and institutions. With its Innovation Hubs, Grünenthal strives to establish centres of excellence for pain research, aiming to identify and develop promising external innovation opportunities in the therapeutic area ...

more
28.01.2020 – 12:00

Sysmex Inostics GmbH
Sysmex Inostics and Oxford Gene Technology plasma and tissue sequencing show clearance of ctDNA correlates with pathologic complete response in breast cancer patients during neoadjuvant treatment

Hamburg, Germany and Baltimore, Maryland (ots) - Pathologist Dr. Vincente Peg of the Vall d´Hebron University Hospital (Barcelona Spain) and colleagues have presented a correlation between the clearance of circulating tumor DNA (ctDNA) in HER2-positive or triple-negative breast cancer patients undergoing ...

more
27.01.2020 – 13:23

Zentiva
Zentiva Celebrates The Parc's Impressive Scientific Track Record in 2019

Prague (ots/PRNewswire) - Zentiva welcomed The Pharmaceutical Applied Research Center (The Parc) to their Prague headquarters to celebrate the first anniversary of The Parc Awards. The Parc is a unique research platform designed to prepare future generations of pharmaceutical scientists and engineers. Twenty-nine students are currently included in the program and an ...

more
13.01.2020 – 11:43

COMPASS Pathways
COMPASS Pathways Granted Patent Covering Use of Its Psilocybin Formulation in Addressing Treatment-resistant Depression

London (ots/PRNewswire) - COMPASS Pathways, a mental health care company, announced today that it has been granted US Patent No 10,519,175, relating to methods of treating drug-resistant depression with a psilocybin formulation, by the US Patent and Trademark Office. The patent covers the use of COMPASS's ...

more

123456Next